Clinical Trial Update: Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of sitagliptin for glucose-lowering effects in adults with Type 2 diabetes mellitus has completed, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Non-Insulin-Dependent | Phase 2 | Status: COMPLETED | Results posted: 2009-09-25